Difference between revisions of "Eye Disease"

From Anthony Nolan Medical Guidelines
Jump to navigation Jump to search
m (Protected "Eye Disease" (‎[edit=sysop] (indefinite) ‎[move=sysop] (indefinite)))
Line 16: Line 16:
 
Unacceptable if malignancy, active inflammation of the eye or transplanted eye tissue (see [[Ocular Tissue Recipient]]).
 
Unacceptable if malignancy, active inflammation of the eye or transplanted eye tissue (see [[Ocular Tissue Recipient]]).
  
Avoid use of G-CSF in those with a history of inflammatory eye disease (e.g.uveitis, scleritis, iritis, episcleritis) unless a clear infectious aetiology has been identified.
+
Unacceptable for PBSC if history of inflammatory eye disease (e.g.uveitis, scleritis, iritis, episcleritis) unless a clear infectious aetiology has been identified. Acceptable for BM provided not associated with severe or multisystem autoimmune disease. Inform TC.
  
Enquire about underlying multisystem autoimmune disease.
 
  
 
Glaucoma is acceptable if any surgical treatment complete and on eyedrops only. Discuss with MO if necessary.
 
Glaucoma is acceptable if any surgical treatment complete and on eyedrops only. Discuss with MO if necessary.

Revision as of 14:23, 1 June 2016

Acceptability at Recruitment

QUALIFIED

Acceptability at CT / Work-Up

QUALIFIED

Individual at Risk

Donor / Recipient

Explanation of Condition

Guidance

Discuss with medical officer.

Unacceptable if malignancy, active inflammation of the eye or transplanted eye tissue (see Ocular Tissue Recipient).

Unacceptable for PBSC if history of inflammatory eye disease (e.g.uveitis, scleritis, iritis, episcleritis) unless a clear infectious aetiology has been identified. Acceptable for BM provided not associated with severe or multisystem autoimmune disease. Inform TC.


Glaucoma is acceptable if any surgical treatment complete and on eyedrops only. Discuss with MO if necessary.

Pseudonyms or Related Conditions

Version

Version 1, Edition 1

Date of Last Update

15th June 2012